Clene Inc.
CLNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822791
No open-market purchases or sales by Clene Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.6M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Clene Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 27 | 24 | −3 |
| Shares | 491.4K | 455.4K | −35.9K (−7.3%) |
| Value | $2.60M | $1.40M | −$1.20M (−46.1%) |
New holders (4)
Institutions that held Clene Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Penn Davis McFarland Inc | 11,000 | $33.9K | 0.00% |
| Sandy Spring Bank | 1,000 | $3.08K | 0.00% |
| Lindbrook Capital, LLC | 100 | $308 | 0.00% |
| JPMorgan Chase & Co | 7 | $22 | 0.00% |
Sold out (7)
Institutions that held Clene Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Citadel Advisors LLC | 20,835 | $110.6K |
| Renaissance Technologies LLC | 18,040 | $95.8K |
| Castleview Partners, LLC | 11,547 | $62.2K |
| Fullcircle Wealth LLC | 13,023 | $59.4K |
| Washington Trust Co | 150 | $797 |
| Wells Fargo & Company | 50 | $266 |
| Citigroup Inc | 1 | $5 |